Document Detail

Molecular magnetic resonance imaging allows the detection of activated platelets in a new mouse model of coronary artery thrombosis.
MedLine Citation:
PMID:  21577120     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: : The final event leading to myocardial infarction is adhesion and activation of platelets after rupture of an atherosclerotic plaque, ending in thrombotic occlusion of the coronary artery. Imaging of imminent vessel occlusion may improve patient care. The feasibility of molecular magnetic resonance imaging (MRI) for the detection of coronary artery thrombosis in mice was examined.
MATERIALS AND METHODS: : The left anterior descending coronary artery was exposed by lateral thoracotomy and incubated with ferric chloride to induce nonocclusive thrombosis in C57Bl/6 mice. A single chain antibody targeting ligand-induced binding sites (LIBS) of the activated glycoprotein IIb/IIIa or control antibody was conjugated to 1 μm-sized microparticles of iron oxide (MPIOs), resulting in LIBS-MPIO or control-MPIO MRI contrast agent, and injected intravenously. Hearts were subjected to histology and ex vivo MRI at 9.4 Tesla.
RESULTS: : Thrombus size was comparable in mice injected with control-MPIO and LIBS-MPIO in histology. Significant binding of MPIOs to thrombi was observed in LIBS-MPIO-injected animals while no binding was observed in control animals (P < 0.05). In MRI, LIBS-MPIO binding to thrombi of the left anterior descending coronary artery resulted in significant MPIO-induced signal void compared with controls (P < 0.05). MRI signal void and the amount of bound contrast agent particles in histology showed a significant positive linear correlation (r = 0.939, P < 0.001).
CONCLUSIONS: : We established a new mouse model of nonocclusive coronary artery thrombosis. LIBS-MPIO contrast agent binds to activated platelets in this model, allowing molecular MRI of coronary thrombosis. This could have important implications on the timely noninvasive detection of arterial thrombosis, helping to initiate early therapeutic interventions.
Daniel Duerschmied; Mirko Meißner; Karlheinz Peter; Irene Neudorfer; Freya Roming; Andreas Zirlik; Christoph Bode; Dominik von Elverfeldt; Constantin von Zur Muhlen
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Investigative radiology     Volume:  46     ISSN:  1536-0210     ISO Abbreviation:  Invest Radiol     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-09-05     Completed Date:  2012-01-26     Revised Date:  2012-10-12    
Medline Journal Info:
Nlm Unique ID:  0045377     Medline TA:  Invest Radiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  618-23     Citation Subset:  IM    
Department of Cardiology and Angiology, University Medical Center Freiburg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Analysis of Variance
Binding Sites
Blood Platelets / metabolism*
Chlorides / diagnostic use
Contrast Media / diagnostic use
Coronary Thrombosis / diagnosis*
Disease Models, Animal
Ferric Compounds / diagnostic use
Magnetic Resonance Imaging / methods*
Mice, Inbred C57BL
Platelet Activation
Platelet Adhesiveness
Platelet Glycoprotein GPIIb-IIIa Complex / pharmacology
Random Allocation
Reg. No./Substance:
0/Chlorides; 0/Contrast Media; 0/Ferric Compounds; 0/Platelet Glycoprotein GPIIb-IIIa Complex; 1309-37-1/ferric oxide; 7705-08-0/ferric chloride

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Free-Breathing Radial 3D Fat-Suppressed T1-Weighted Gradient Echo Sequence: A Viable Alternative for...
Next Document:  Free-Breathing Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging in a Rat Liver Tumo...